Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving Rotavirus Vaccine Immunogenicity in Bangladeshi Infants
NCT01825109Phase 3Completed
- Sponsor
- icddr,b
- Start
- Jul 2010
- Primary completion
- Apr 2011
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rotavirus vaccine, live, oral in rotavirus gastroenteritis (4 arms), sponsored by icddr,b. Primary endpoint: Sero-conversion rate of anti-rotavirus IgA. Started Jul 2010; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT01825109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01825109.